Loading...
IceCure Medical Ltd
ICCM•NASDAQ
Healthcare
Medical - Devices
$1.05
$0.04(4.46%)
IceCure Medical Ltd (ICCM) Financial Performance & Statements
Review IceCure Medical Ltd’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
1.92%
↑ 1.92%
Operating Income Growth
-0.77%
↓ 0.77%
Net Income Growth
-4.55%
↓ 4.55%
Operating Cash Flow Growth
-0.34%
↓ 0.34%
Operating Margin
-479.77%
↓ 479.77%
Gross Margin
42.77%
↑ 42.77%
Net Profit Margin
-467.37%
↓ 467.37%
ROE
-182.26%
↓ 182.26%
ROIC
-257.09%
↓ 257.09%
IceCure Medical Ltd (ICCM) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for IceCure Medical Ltd stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $875000.00 | $662000.00 | $1.01M | $736350.00 |
| Cost of Revenue | $458000.00 | $427000.00 | $481000.00 | $469757.00 |
| Gross Profit | $417000.00 | $235000.00 | $530000.00 | $266593.00 |
| Gross Profit Ratio | $0.48 | $0.35 | $0.52 | $0.36 |
| R&D Expenses | $1.70M | $1.86M | $1.58M | $1.93M |
| SG&A Expenses | $3.25M | $2.66M | $2.17M | $1.95M |
| Operating Expenses | $4.94M | $4.53M | $3.76M | $3.88M |
| Total Costs & Expenses | $5.40M | $4.96M | $4.24M | $4.35M |
| Interest Income | $0.00 | $0.00 | $147000.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $82000.00 | $83000.00 | $82000.00 | $84239.00 |
| EBITDA | -$4.44M | -$4.21M | -$3.15M | -$3.56M |
| EBITDA Ratio | -$5.08 | -$6.36 | -$3.11 | -$4.84 |
| Operating Income | -$4.53M | -$4.29M | -$3.23M | -$3.62M |
| Operating Income Ratio | -$5.17 | -$6.48 | -$3.19 | -$4.91 |
| Other Income/Expenses (Net) | $46000.00 | $144000.00 | $147000.00 | $41000.00 |
| Income Before Tax | -$4.48M | -$4.15M | -$3.08M | -$3.58M |
| Income Before Tax Ratio | -$5.12 | -$6.27 | -$3.05 | -$4.86 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$4.48M | -$4.15M | -$3.08M | -$3.58M |
| Net Income Ratio | -$5.12 | -$6.27 | -$3.05 | -$4.86 |
| EPS | -$0.09 | -$0.08 | -$0.06 | -$0.08 |
| Diluted EPS | -$0.09 | -$0.08 | -$0.06 | -$0.08 |
| Weighted Avg Shares Outstanding | $55.55M | $52.39M | $49.23M | $46.74M |
| Weighted Avg Shares Outstanding (Diluted) | $55.55M | $52.39M | $49.23M | $46.74M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan